F. Heuck

Attenuation Correction of Somatostatin Receptor SPECT by Integrated Low-Dose CT: Is There an Impact on Sensitivity?

I. Steffen, H. Amthauer, C. Furth, 2009, Clinical nuclear medicine.

Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

H. Amthauer, B. Wiedenmann, M. Pavel, 2009, Neuroendocrinology.

68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol

H. Amthauer, B. Wiedenmann, M. Pavel, 2011, The Journal of Nuclear Medicine.

The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis.

P. Borchmann, A. Rothe, A. Engert, 2004, Blood.

Incidental detection of breast cancer by 68Ga-DOTATOC-PET/CT in women suffering from neuroendocrine tumours

I. Steffen, H. Amthauer, J. Ruf, 2008, Nuklearmedizin.

Combination of the Human Anti-CD30 Antibody 5F11 with Cytostatic Drugs Enhances Its Antitumor Activity against Hodgkin and Anaplastic Large Cell Lymphoma Cell Lines

P. Borchmann, A. Rothe, E. P. von Strandmann, 2004, Journal of immunotherapy.

Open-label, non-randomized, multicenter phase II study evaluating the angiogenesis inhibitor PTK787/ ZK222584 (PTK/ZK) in patients with advanced neuroendocrine carcinomas (NEC)

B. Wiedenmann, M. Pavel, F. Neumann, 2008 .

Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

H. Amthauer, B. Wiedenmann, M. Pavel, 2009, Neuroendocrinology.